Search research articles
Contact Us
Filters
Showing results (251-260 of 382) with videos related to
Page
of 39
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2001
Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma
A Lafuma, B Dreno, M Delaunay, et al.
Lancet (London, England)
|
December 23, 1995
Natural history of untreated cytomegalovirus retinitis
E F Bowen, P Wilson, M Atkins, et al.
FEBS Letters
|
September 4, 1995
Beta-sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopy
C G Ullman, P I Haris, K F Smith, et al.
Lancet (London, England)
|
June 29, 2004
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
Jane R Deayton, Caroline A Prof Sabin, Margaret A Johnson, et al.
Lancet (London, England)
|
July 8, 2000
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
V C Emery, C A Sabin, A V Cope, et al.
Transplantation
|
September 19, 2007
Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation
Gaia Nebbia, Frank M Mattes, Caroline A Sabin, et al.
Neuropharmacology
|
February 22, 2015
Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism
Hannah A Hathaway, Sergey Pshenichkin, Ewa Grajkowska, et al.
The Journal of Infectious Diseases
|
January 7, 1998
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group
P D Griffiths, J E Feinberg, J Fry, et al.
Virology
|
April 1, 1989
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus
K Takehara, M K Min, J K Battles, et al.
Journal of Medical Virology
|
September 29, 1999
Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients
M Grzywacz, J R Deayton, E F Bowen, et al.
Page
of 39
Search research articles
Search
Showing results (251-260 of 382) with videos related to
Sort By:
Page
of 39
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2001
Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma
A Lafuma, B Dreno, M Delaunay, et al.
Lancet (London, England)
|
December 23, 1995
Natural history of untreated cytomegalovirus retinitis
E F Bowen, P Wilson, M Atkins, et al.
FEBS Letters
|
September 4, 1995
Beta-sheet secondary structure of an LDL receptor domain from complement factor I by consensus structure predictions and spectroscopy
C G Ullman, P I Haris, K F Smith, et al.
Lancet (London, England)
|
June 29, 2004
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
Jane R Deayton, Caroline A Prof Sabin, Margaret A Johnson, et al.
Lancet (London, England)
|
July 8, 2000
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
V C Emery, C A Sabin, A V Cope, et al.
Transplantation
|
September 19, 2007
Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation
Gaia Nebbia, Frank M Mattes, Caroline A Sabin, et al.
Neuropharmacology
|
February 22, 2015
Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism
Hannah A Hathaway, Sergey Pshenichkin, Ewa Grajkowska, et al.
The Journal of Infectious Diseases
|
January 7, 1998
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group
P D Griffiths, J E Feinberg, J Fry, et al.
Virology
|
April 1, 1989
Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus
K Takehara, M K Min, J K Battles, et al.
Journal of Medical Virology
|
September 29, 1999
Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients
M Grzywacz, J R Deayton, E F Bowen, et al.
Page
of 39